Literature DB >> 21756896

Activation of lipoprotein lipase increases serum high density lipoprotein 2 cholesterol and enlarges high density lipoprotein 2 particles in rats.

Masataka Kusunoki1, Kazuhiko Tsutsumi, Daisuke Sato, Aki Nakamura, Satoshi Habu, Yuichi Mori, Munehiko Morishita, Takayuki Yonemoto, Tetsuro Miyata, Yutaka Nakaya, Takao Nakamura.   

Abstract

It is known that postheparin plasma lipoprotein lipase (LPL) activity correlates with serum high density lipoprotein cholesterol (HDL-C) levels in humans and animals. Furthermore, LPL has been reported to cause enlargement of HDL particle size in vitro. However, these effects have not yet been experimentally proven. The aim of this study was to determine whether LPL has a role in increase in HDL-C and enlargement of HDL particle by activating the LPL function with NO-1886, the LPL promoting agent. NO-1886 administration increased postheparin plasma LPL activity without influencing hepatic triglyceride lipase activity. NO-1886 increased serum HDL(2)-cholesterol (HDL(2)-C) concentration and enlarged HDL(2) particle size, but did not increase serum HDL(3)-cholesterol concentration or enlarge HDL(3) particle size. Also, serum HDL(2)-C concentrations were positively correlated with HDL(2) particle size (r=0.910). Our study demonstrates that the LPL activation induced with NO-1886 may cause production of HDL(2)-C by catabolism of triglyceride-rich lipoproteins and enlarges HDL(2) particle size in rats.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21756896     DOI: 10.1016/j.ejphar.2011.06.040

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Proprotein convertases in high-density lipoprotein metabolism.

Authors:  Seungbum Choi; Ron Korstanje
Journal:  Biomark Res       Date:  2013-09-18

Review 2.  Lipoprotein Lipase (LPL) Polymorphism and the Risk of Coronary Artery Disease: A Meta-Analysis.

Authors:  Li Xie; You-Mei Li
Journal:  Int J Environ Res Public Health       Date:  2017-01-16       Impact factor: 3.390

3.  Atherogenic dyslipidemia in children: evaluation of clinical, biochemical and genetic aspects.

Authors:  Anna Montali; Gessica Truglio; Francesco Martino; Fabrizio Ceci; Giampiero Ferraguti; Ester Ciociola; Marianna Maranghi; Francesco Gianfagna; Licia Iacoviello; Roberto Strom; Marco Lucarelli; Marcello Arca
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.